Two Autoimmune CAR-T Leaders Reveal Latest Data: One 'Global First', One 'First to Market'
Jun 06, 2026 07:20
CST Updated
10:36
Kyverna
Developer of Immunocyte Therapy
Cabaletta Bio
Targeted Cell Therapy Developer